Cardiology

Nexstim Plc manufactures navigated transcranial magnetic stimulation (nTMS) and repetitive TMS (rTMS) systems for clinical diagnosis, surgical planning, and therapeutic applications. The company's primary products are the SmartFocus® nTMS and NBS System platforms, which use 3D imaging and image-guided navigation to precisely target and quantify the electric field dose delivered to the brain. Clinical applications include motor and language mapping for presurgical planning in neurosurgery and epilepsy, treatment of major depressive disorder (FDA cleared), obsessive-compulsive disorder (OCD; FDA cleared as of 2026), and post-operative rehabilitation for spinal cord injury and complex regional pain syndrome (CRPS). The systems are used in academic medical centers, children's hospitals, and specialized neurosurgery and psychiatry clinics worldwide. Nexstim holds FDA 510(k) clearances and CE/MDR certification for multiple therapeutic indications. The company serves neurosurgeons, neuroradiologists, epileptologists, psychiatrists, and rehabilitation specialists. The technology integrates real-time neurophysiological feedback (motor evoked potentials, MEP recording) with anatomical imaging to guide clinical decision-making and optimize patient outcomes.

Anika Therapeutics is a global leader in hyaluronic acid (HA)-based orthopedic regenerative solutions and osteoarthritis pain management. Founded with 30+ years of HA expertise, the company develops and markets innovative treatments addressing rotator cuff and tendon repair, cartilage regeneration, bone augmentation, and non-opioid osteoarthritis pain management. The company operates through two primary product platforms: Regenerative Solutions (tissue repair and scaffold-based regeneration) and OA Pain Management (HA viscosupplements and combination therapies). Key products include Integrity (HA-based rotator cuff and tendon repair augmentation), Hyalofast (cartilage regeneration scaffold), Tactoset (injectable bone substitute), NanoFx (bone marrow stimulation), Cingal (combination HA + steroid injection), Monovisc (single-injection HA viscosupplement), and Orthovisc (multi-injection HA viscosupplement). Products are clinically validated with robust safety and efficacy data supporting use in orthopedic surgery and rheumatology. Anika maintains US headquarters in Bedford, MA, with operational offices in Warsaw, IN, and significant EU presence in Padova, Italy. The company distributes products in 45+ countries globally through direct sales, distribution partnerships, and strategic alliances including J&J MedTech for US Orthovisc and Monovisc distribution. Regulatory credentials and certifications align with FDA, CE marking, and ISO standards for medical devices. The company serves orthopedic surgeons, rheumatologists, pain management specialists, and healthcare institutions seeking regenerative and conservative OA treatment alternatives.

CivaTech Oncology Inc. is a North Carolina-based medical device manufacturer specializing in innovative low dose rate (LDR) brachytherapy systems for cancer treatment. The company designs and commercializes polymer-encapsulated radioactive source devices that deliver localized radiation therapy to solid tumors while minimizing procedure time, trauma, and patient morbidity. Primary product lines include CivaString®, a linear polymer-encapsulated LDR brachytherapy source for treating prostate and other localized solid tumors; CivaSheet®, the only FDA-cleared unidirectional, bioabsorbable planar brachytherapy source; and CivaDerm™, a temporary radiation therapy product for intraoperative or surface treatment of skin cancer and other lesions. All products feature proprietary polymer encapsulation technology that eliminates hot/cold dose distribution spots, prevents source migration, and avoids long-term metal toxicity concerns associated with traditional metallic seeds. CivaString® and CivaSheet® are approved by the FDA and Nuclear Regulatory Commission as sealed sources for treating cancers of any solid tumor type, including prostate, pancreatic, sarcoma, head and neck, gynecologic, colorectal, breast, and brain malignancies. The company holds two NRC licenses in North Carolina (Agreement State), permitting broad research and manufacture/distribution of radioactive materials. Manufacturing operations comply with FDA guidelines and ISO 13485 international standards for medical device production in a cleanroom environment. The company has received NIH/NCI support and has published clinical outcomes demonstrating efficacy and safety. CivaTech's brachytherapy devices integrate seamlessly into existing clinical workflows from imaging through treatment planning and post-implant dosimetry.

Norwood Medical is a contract manufacturer and precision engineering partner specializing in medtech component and device manufacturing. Operating from a 700,000 square-foot manufacturing campus in Dayton, Ohio, the company serves leading surgical device manufacturers across cardiovascular, minimally invasive surgery (MIS), orthopedic, and robotic-assisted surgery (RAS) markets. Founded nearly a century ago, Norwood offers end-to-end capabilities spanning design for manufacturability (DFM), engineering, prototyping, tooling development, precision machining, metal injection molding (MIM), electro-chemical machining (ECM), automation, secondary processing, assembly, testing, and packaging. The company operates over 800 CNC machines (milling, turning, 5-axis, Swiss machining), automated robotic systems with vision and laser technology, and specialized electrochemical machining equipment. Norwood manufactures components at tight tolerances for complex surgical instruments and implantable devices, with in-house capabilities for metal injection molding feedstock mixing and insert molding. The firm maintains strong quality and on-time delivery metrics and serves as sole supplier to approximately 32% of its customer base. Quality certifications and regulatory compliance capabilities support OEM partners across FDA-regulated device categories.

Catalyst MedTech is a leading provider of new and refurbished nuclear medicine and molecular imaging equipment, with specialized focus on PET, PET/CT, SPECT, and dedicated Brain PET systems. The company operates as a multi-vendor ecosystem partner serving OEMs, healthcare systems, imaging centers, hospitals, and specialty practices in cardiology and neurology. Core competencies include equipment sales and distribution, clinical diagnostic imaging solutions, and comprehensive service delivery through a nationwide network of service technicians. Catalyst MedTech holds ISO 13485:2016 certification covering sales, repair, refurbishment, installation, and servicing of medical imaging devices. The company positions itself as a workflow and clinical solutions partner, blending equipment, service expertise, and operational support to help practices scale operations. Target markets include nuclear medicine imaging centers, cardiology practices with advanced imaging, neurology departments, and larger healthcare systems seeking multi-vendor support and optimization. The company actively participates in industry events including FNMT, AAMI, and cardiology forums, indicating engagement with clinical imaging professionals and hospital administrators.

Zimmer MedizinSystems is the U.S. distribution arm of Zimmer MedizinSysteme GmbH, a German manufacturer with over 50 years of experience in medical device development. The company manufactures and distributes advanced energy-based technologies and systems for aesthetics, physiotherapy, athletic recovery, physical medicine, and cardiology. Product portfolio includes cryo therapy systems for aesthetic and physical medicine applications; ultrasound therapy devices; electrotherapy and e-stim equipment; laser and IPL systems for skin treatment and body contouring; radial and focused shockwave therapy systems (including the DualWave FX focused shockwave platform); RF/TECAR technology; and high-energy inductive therapy (HEIT) systems such as the emFieldPro. The company also supplies diagnostic and cardiology technologies. Zimmer MedizinSystems maintains U.S. offices in Irvine, California (headquarters) and Allentown, Pennsylvania, providing dual time-zone coverage for sales, technical support, service, and maintenance. The parent company manufactures in Germany and has established distribution and support infrastructure across North America. Products are designed for clinical use in dermatology, aesthetic medicine, chiropractic, sports medicine, physical therapy, and cardiology practices. The company emphasizes comprehensive product support including device registration, maintenance programs, and calibration services. All products carry appropriate regulatory markings for U.S. market distribution.

AGFA HealthCare is a global leader in enterprise imaging and diagnostic imaging software solutions serving healthcare organizations worldwide. The company develops and delivers an integrated Enterprise Imaging platform that consolidates PACS (Picture Archiving and Communication Systems), imaging analytics, and clinical workflows across multiple imaging modalities including radiology, cardiology, breast imaging, molecular imaging, digital pathology, POCUS (point-of-care ultrasound), teleradiology, medical photography, and specialty areas including dental, ophthalmology, and orthopedics. The Enterprise Imaging platform is engineered around clinician-first design principles, offering seamless workflow integration, blazing-fast streaming access, and specialty-tailored clinical workspaces. Key product components include: Streaming Client (web-based diagnostic access), XERO Universal Viewer (patient-centric cross-specialty imaging), Vendor Neutral Archive (VNA) for multimedia data consolidation, RUBEE AI (augmented intelligence ecosystem), RUBEE Orchestrator (workflow automation and orchestration), Business Intelligence tools, and Enterprise Imaging Scheduling. AGFA HealthCare delivers solutions across multiple deployment models: on-premises, cloud (SaaS), and hybrid architectures, utilizing cloud-native microservices. The platform is built with security-by-design principles, incorporating encryption, access control, auditing, and compliance frameworks. The company serves hospitals, health networks, and healthcare organizations of varying digital maturity and scale, from individual facilities to large enterprise systems. Services include hands-on onboarding, role-specific training programs, clinical coaching, customer experience center collaboration, CE credit programs, and 24/7 operational support. AGFA HealthCare has received recognition as "Best in KLAS" for 2026 across multiple enterprise imaging segments and maintains established partnerships and deployments globally.

LifeSign LLC is a medical diagnostic company specializing in high-quality rapid point-of-care (POC) testing solutions for the healthcare industry. The company manufactures and distributes a comprehensive portfolio of diagnostic test kits and reagents across multiple clinical specialties, including infectious disease, women's health, cardiac care, urology, gastrointestinal health, drugs of abuse screening, hygiene, and industrial applications. Key product lines include the Status™ rapid test platform, covering COVID-19/Flu A&B multiplex testing, influenza B, mononucleosis, and strep A detection. LifeSign serves hospitals, clinics, urgent care centers, and other healthcare facilities requiring rapid, reliable diagnostic results at the point of care. The company emphasizes early detection and rapid diagnosis to improve clinical outcomes. LifeSign maintains manufacturing and quality systems appropriate for medical device distribution, with products distributed through a national sales and support network. The organization is positioned as a B2B supplier of diagnostic consumables and testing solutions for various medical markets.

Medical Metrics, Inc. (MMI) is an independent, full-service imaging core laboratory and clinical consulting firm specializing in centralized image analysis, endpoint strategy design, and regulatory support for clinical trials and medical device development. Founded 21+ years ago, MMI serves over 260 clients and partners globally, having supported 695+ clinical trials and contributed to more than 50 FDA regulatory approvals and clearances. The company operates a science-first approach with a multidisciplinary team of biomedical engineers, medical imaging specialists, and physician reviewers who design customized imaging methodologies and protocols for device sponsors, biopharmaceutical companies, and contract research organizations. Core services include imaging endpoint strategy and scientific consulting, image review charter development, clinical site management and training, image quality and compliance monitoring, expert centralized image analysis (via independent physician readers), data interpretation, publication strategy, and post-market surveillance. MMI maintains expertise across multiple therapeutic areas including spine (fusion, motion preservation, deformity correction), orthopedics (joint arthroplasty, biologics, cartilage repair), cardiovascular (peripheral vascular disease, atherectomy, stents), neurology (stroke, aneurysm, tumor), ENT, gastrointestinal and urology, oncology, and artificial intelligence research. The firm is ISO 13485 certified and operates with emphasis on accuracy, reliability, independence, and integrity in imaging outcomes assessment.

Avanos Medical, Inc. is a specialized medical device manufacturer focused on two core therapeutic areas: enteral feeding solutions and pain management & recovery. The company develops and markets a comprehensive portfolio of specialty nutrition delivery systems for neonates, pediatric, adult, and geriatric patients, along with non-opioid pain management and post-operative recovery solutions. Key product lines include MIC-KEY® low-profile feeding tubes, CORTRAK® NG tube guidance systems, NEOMED® neonatal solutions, GAME READY® cryo-compression therapy, COOLIEF® cooled radiofrequency systems, and ON-Q® elastomeric infusion pumps. The ON-Q® and ambIT® infusion pumps are recognized under the CMS NOPAIN Act (effective January 1, 2025) as qualifying non-opioid pain management solutions eligible for separate reimbursement. Avanos serves critical care physicians, anesthesiologists, interventional pain specialists, orthopedic surgeons, sports medicine practitioners, neonatologists, and NICU professionals. The company operates a direct customer portal for online ordering, maintains a 24/7 nurse hotline for surgical pain product support, and provides sales representation across North America. Avanos markets solutions emphasizing improved patient outcomes, reduced opioid dependency, and clinical efficacy in both acute surgical settings and chronic pain management.

Dynarex Corporation is a full-service medical supply company founded in 1967, serving healthcare facilities, distributors, and retail partners across the United States. The company operates as a one-stop supplier of medical consumables, devices, and specialty products with a stated commitment to not selling directly to end-users, positioning itself exclusively as a B2B supplier and distributor partner. Product portfolio spans multiple categories: respiratory therapy solutions under the RESP-O2 brand, including oxygen concentrators (10L and other capacities), aerosol therapy equipment, tracheostomy care supplies, and oxygen delivery consumables; advanced wound care via the Durma brand, encompassing moisture-management dressings, medicated wound dressings, and negative pressure wound therapy (NPWT) systems; bariatric medical products under BariMax for larger-frame patient populations; infection control and safety supplies under DynaSafety; laboratory and diagnostic products via LabChoice; and emergency/code blue response supplies under Code Blue Care. Additional offerings include baby care products (talc-free formulations), antifungal powders, and various consumables commonly stocked in pharmacy and retail settings. The company serves multiple market segments including acute care hospitals, long-term care facilities, home health agencies, ambulatory care centers, pharmacies, and retail medical suppliers. Dynarex emphasizes product quality, regulatory compliance, and distributor-focused customer service. The organization maintains distribution partnerships and actively recruits distributors through its partner program.

1st Line Medical Inc. is a US-based sleep medicine and obstructive sleep apnea (OSA) solutions provider headquartered in Holderness, NH. The company manufactures and distributes FDA-cleared home sleep testing systems and oral appliance therapy devices designed to simplify and accelerate OSA diagnosis and treatment. Primary product lines include the SleepImage NightOwl home sleep testing system (wearable ring-based diagnostic) and SomnoGuard custom oral appliances (AP2 and SPX models), which represent alternatives to CPAP therapy for OSA and snoring management. The company also distributes Airlift hyoid suspension information for surgical candidates. 1st Line Medical serves airway specialist physicians, sleep medicine practitioners, and patients across the United States through a direct-to-provider and patient-facing model. The organization emphasizes rapid diagnostic pathways and treatment initiation, positioning products as time- and cost-effective solutions compared to traditional multi-month OSA diagnostic and therapeutic workflows. Products are FDA cleared for home use and carry regulatory approval for both diagnostic and therapeutic applications. The company provides physician training through the SomnoGuard Academy, practice support tools, prescription programs, and dedicated customer service (9 AM–5 PM EST, Monday–Friday). Distribution includes direct reordering of devices and supplies through their web portal.

.decimal LLC is a US-based precision manufacturer of custom, patient-specific treatment devices for cancer radiotherapy. The company specializes in on-demand design and manufacturing of beam-shaping devices and boluses used in proton, electron, and photon therapy treatments. Operating from Sanford, Florida, .decimal serves 949 clinics across the United States, with cumulative production exceeding 533,954 devices treating over 152,000 patients. Product portfolio includes FlexiBol custom silicone boluses, standardized bolus sheets and scalps, blue wax uniform-thickness boluses, electron apertures and blocks, electron bolus systems (BolusECT), 3D scanning technology (decimal3D), GRID therapy devices, photon compensators for IMRT, and proton apertures and range compensators. All devices are manufactured in the US with high-quality raw materials and documented material safety data. .decimal operates a direct-order platform (.decimal Direct) enabling clinics to place and track orders in real time. The company maintains operational hours 8:00 AM–5:00 PM Eastern Time and provides comprehensive customer support through its sales and customer service teams. Beyond custom manufacturing, .decimal offers contract manufacturing services through dotdmachining.com, extending capabilities to other medical device manufacturers. The company serves academic medical centers, community oncology practices, and specialized radiation therapy facilities nationwide.

Actuated Medical develops patented platform technologies for minimally-invasive brain access, implant insertion, and therapeutic delivery. The company specializes in two primary product lines: the NeuralGlider Inserter, which uses micro-oscillation technology to insert brain implants with improved precision and reduced tissue trauma, enhancing implant performance and longevity; and the NeuralGlider Injector, which enables targeted drug delivery deep into the brain using finer, less-invasive needles to minimize tissue damage and medication loss. These technologies serve partners developing deep brain stimulation (DBS), neurological implants, and intracranial drug therapies for conditions including Parkinson's disease, epilepsy, treatment-resistant neurological disorders, brain cancer, AAV gene therapy, and addiction treatments. Actuated Medical positions itself as a foundational platform provider that collaborates with leading innovators in neurotechnology and brain therapeutics. The company has demonstrated significant scientific traction through peer-reviewed publications and preclinical validation studies. Their technology addresses critical clinical needs in neurological treatment where precise brain access and minimal tissue trauma directly impact patient outcomes and long-term implant efficacy.

Medfex is a B2B medical equipment distributor and manufacturer based in Mexico City with 30 years of industry experience (since 1987). The company specializes in importing and distributing diagnostic, respiratory, and orthopedic medical equipment from the USA, with all products registered with COFEPRIS and compliant with Mexican Official Standards (NOM). Medfex operates exclusively on a B2B model, selling through authorized distributors rather than directly to end users. The company serves a broad network including medical supply shops, hospitals, government agencies, and healthcare providers across Mexico, the United States, and Europe. Their product portfolio encompasses blood pressure monitoring devices (aneroid sphygmomanometers), stethoscopes, oxygen therapy equipment, and hospitalization supplies. Medfex emphasizes quality, innovation, and continuous portfolio evolution to maintain technological leadership in medical equipment distribution.

TheraBionic Inc. is an innovative medical device company specializing in cancer treatment through patented tumor-specific radiofrequency technology. The company manufactures the TheraBionic P1 device, an FDA-approved therapeutic system for advanced hepatocellular carcinoma (HCC)—the most common form of liver cancer—in patients who have failed first and second-line therapies. The TheraBionic P1 delivers amplitude-modulated radiofrequency electromagnetic fields (27.12 MHz) via a spoon-shaped antenna placed on the tongue, enabling systemic delivery of low-level, tumor-specific frequencies from head to toe. Clinical studies spanning over two decades demonstrate efficacy in tumor shrinkage, blocking new cancer cell growth, and improving overall survival rates. The device is compact, portable, and notably free of the debilitating side effects associated with conventional chemotherapy and other cancer treatments. TheraBionic's technology represents a breakthrough in non-toxic, systemic targeted therapy for difficult-to-treat cancers.

Macan Genesis Manufacturing LLC is a specialized manufacturer of electrosurgical units with over 60 years of industry experience. The company focuses exclusively on radio frequency (RF) and high-frequency technology for surgical applications, serving both dental and medical markets. Macan designs and manufactures precision electrosurgical units featuring spark-free RF technology, bipolar coagulation handpieces, and surgical tissue management solutions. The company emphasizes quality, safety compliance, and engineering excellence to meet the exacting demands of healthcare professionals. Products are built to deliver reliability and effectiveness in precision tissue cutting and coagulation procedures.

Conductive Technologies Inc. (CTI) is a contract manufacturer specializing in printed electronics and biosensors for the medical device and industrial markets. Founded in 1970 and based in York, Pennsylvania, CTI operates a 110,000 sq. ft. facility with approximately 61 employees and generates $15.4 million in annual revenue. The company holds FDA compliance and ISO 13485 (medical devices) and ISO 9001 certifications, supporting full medical device project development from conception through FDA clearance. CTI's core competencies include electrochemical sensors, biosensors, flexible circuits, and membrane switches. The company manufactures disposable glucose test strips, multiplexed point-of-care diagnostic sensors, wearable devices, and biochips/microfluidics. Manufacturing capabilities include precision laser ablation, fine-line screen printing, and flexible printed circuitry with diverse inks and materials. CTI offers design innovation, development services, and post-commercialization collaboration, particularly for next-generation disposable diagnostic biosensors and Phase Zero Sensors for early-stage biochemical assay development. The structured development process ensures products meet customer requirements and market competitiveness.

General Physiotherapy II LLC manufactures G5® brand electromechanical massage and percussion modalities, recognized globally as the most powerful, reliable, and durable therapeutic devices. With over 60 years of industry experience and more than 250,000 units sold worldwide, G5 devices are the standard equipment for respiratory therapists, physical therapists, chiropractors, sports medicine practitioners, and spa professionals. The company produces proprietary percussion technology featuring multidirectional movements and variable speed settings to deliver deep tissue massage and percussion without therapist fatigue. G5 devices are engineered with over-specified power supplies and motors designed for clinical longevity (with documented usage exceeding 20-40 years). Products are used across professional sports globally, including FIFA and NFL teams. The company operates manufacturing facilities in St. Louis, Missouri and Casteljaloux, France, distributing products worldwide. G5 modalities complement hands-on therapy techniques, improve patient outcomes, reduce pharmaceutical dependency, and enable therapists to treat more clients per session.

GVS Filter Technology is a global manufacturer of advanced filtration solutions established in 1979 and headquartered in Zola Predosa, Italy. With approximately 2,500–4,386 employees operating 18 production plants and 30 commercial offices worldwide, GVS specializes in filter materials, filters, and microfiltration components for highly regulated sectors including Healthcare & Life Sciences, Energy & Mobility, and Health & Safety. The company serves critical medical applications including MedTech product development, blood filtering and transfusion medicine, diagnostics, bioprocessing, and respiratory protection. GVS provides both custom filter solutions and off-the-shelf components designed to streamline customer product development across clinical, laboratory, and industrial environments. The company reported approximately $470 million in revenue and maintains ISO certifications with emphasis on quality, innovation, and sustainability.

Fortis Life Sciences is a strategic platform company based in Waltham, Massachusetts, founded in August 2020. It operates as a multi-subsidiary life sciences tools provider delivering specialized reagents, diagnostic components, and custom development services to biopharma, diagnostics, and research organizations globally. The company integrates five ISO 13485 certified and GMP-compliant North American manufacturing and R&D locations under its "Farm-to-Bench" system, spanning antibody discovery and production, viral vector manufacturing, nanoparticle synthesis, molecular biology reagents, and diagnostic component CDMO services. Core product portfolio includes premium monoclonal and recombinant antibodies (validated for ELISA, Western blot, IHC, flow cytometry, spatial biology), VHH domain libraries (AbNano platform), lateral flow immunoassay components, assay-grade enzymes and master mixes, diagnostic grade nanoparticles (gold, platinum, silica), and lentiviral and AAV vector production. The company also offers contract manufacturing, antibody development, spatial biology imaging services, and precision lyophilization for stable diagnostic products. It serves over 10,000 customers across biopharma, diagnostics OEMs, contract manufacturers, academic research, and applied technology sectors.

Eckert & Ziegler SE is a leading global provider of isotope technology for medical, scientific, and industrial applications. Headquartered in Berlin and listed on the Frankfurt Stock Exchange (TecDAX), the company specializes in cancer therapy, nuclear-medical imaging, and industrial radiometry. With approximately 1,143 employees, Eckert & Ziegler manufactures pharmaceutical-grade radioactive ingredients for cancer treatment and diagnosis. The company's core competencies include radiopharmaceutical synthesis, brachytherapy sources, hot cell solutions, and radiosynthesis technology. Its medical products segment delivers radioactive compounds for oncology and diagnostic imaging, while the isotope products segment manufactures radiation sources for medical and industrial applications. Eckert & Ziegler also develops quality control instruments and theranostic solutions, including specialized products such as Lutetium-177. The company has achieved significant market presence across Europe and North America through strategic acquisitions and partnerships.

Kaléo is a pharmaceutical company specializing in drug-device combinations, particularly innovative auto-injector systems. Founded by twin brothers Eric and Evan Edwards and based in Glen Allen, Virginia, Kaléo designs and manufactures auto-injectors for urgent medical conditions with an emphasis on patient safety, ease of use, and reliability. The company's proprietary Aerio™ platform leverages Human Factors Engineering and fully automated manufacturing to deliver precision drug-delivery devices adaptable across multiple disease categories and environments. Kaléo's marketed portfolio includes AUVI-Q® (epinephrine auto-injector for severe allergies), naloxone auto-injectors for opioid overdose response, and medical countermeasures for nerve agent exposure and chemical threats. The company partners with pharmaceutical manufacturers and government agencies to develop custom drug-delivery solutions and maintains a strong commitment to patient access through financial assistance programs. With approximately 155 issued or pending patents, Kaléo serves both civilian healthcare markets and specialty applications including emergency medicine and global health security.

Pharaoh Neuro, Inc. develops the Neurapheresis™ platform, an investigational extracorporeal cerebrospinal fluid (CSF) filtration therapy designed to remove foreign constituents, pathogens, and blood degradation products from the CSF in neurocritical patients. The company, founded in 2017 as a collaboration between Minnetronix Neuro and Duke University Medical Center, focuses on restoring CSF balance to protect brain health and improve outcomes in patients with acute neurological conditions. Current clinical initiatives include subarachnoid hemorrhage (SAH), cryptococcal meningitis, and leptomeningeal carcinomatosis. The Neurapheresis™ system operates via spinal catheter extension, offering precision management of intracranial pressure and metabolic waste clearance in the neurocritical care setting. The device is currently in clinical investigation under FDA Investigational Device Exemption (IDE) and has not yet received FDA clearance or approval for commercial distribution in the United States.

CNMC Company is a specialized supplier of radiation physics and quality assurance equipment serving the medical radiation community. The company provides a comprehensive portfolio of dosimetry devices, ionization chambers, survey meters, brachytherapy accessories, phantoms, and calibration services. CNMC specializes in products for linear accelerator QA/QC, diagnostic radiology, brachytherapy localization, IMRT planning, and radiation protection. The product range includes electrometers, diode and MOSFET dosimeters, TLD dosimeters, ion chamber survey meters, personal dosimeters, various ionization chamber types, positioning and immobilization devices, and custom QA phantoms. The company also offers repair services and unparalleled customer support with custom product development capabilities.

Noul Co., Ltd. is a South Korean biotechnology company founded in 2015, specializing in AI-powered in vitro diagnostics and remote diagnosis solutions for infectious and non-infectious diseases. The company's flagship miLab™ platform is an advanced digital diagnostic system that automates blood analysis, sample preparation, and AI-driven pathology interpretation. Noul's product portfolio addresses critical global healthcare challenges, focusing on malaria diagnosis, complete blood count (CBC) and cell morphology analysis, and early cervical cancer detection through AI-powered cytology. The company has established international partnerships and distribution agreements, with presence across multiple countries. Noul's technology delivers significant improvements in diagnostic accessibility, speed (>2x reduction in analysis time), and accuracy, with clinical validation demonstrating high sensitivity and specificity. The company is committed to scaling diagnostic innovation globally, with a vision to impact one billion lives by 2030 through timely, accessible diagnostics for resource-limited and developed healthcare settings.

Dentacraft Instruments is a premier manufacturer of high-grade stainless steel surgical, dental, and veterinary instruments, established nearly three decades ago. The company combines traditional craftsmanship with advanced manufacturing techniques to deliver precision instruments renowned for durability, reliability, and exceptional performance. Operating from a state-of-the-art facility in Sialkot, Pakistan, Dentacraft leverages cutting-edge machinery for production stages while employing skilled artisans for hand-finishing, shaping, aligning, and polishing. The company is ISO 9001:2008 and ISO 13485:2003 certified, FDA-approved, and CE-marked, with products meeting international quality standards. Dentacraft serves surgical and dental professionals globally through distributors and suppliers, offering lifetime warranties and on-time delivery. The organization is committed to quality, innovation, efficiency, reliability, competitive pricing, and exceptional customer care.

Abingdon Health plc is a UK-based public limited company specializing in contract research, development, and manufacturing of lateral flow assay diagnostic tests. Headquartered at York Biotech Campus with operations in Doncaster, UK and Madison, Wisconsin, the company serves global clients across healthcare, animal health, and plant health sectors. Abingdon Health offers comprehensive lateral flow services from concept to commercial launch, including contract LFT development, scale-up and technical transfer, contract manufacturing, regulatory consultancy, quality assurance, analytical testing, and commercial support. The company provides flexible manufacturing solutions encompassing reagent preparation, spraying, lamination, kitting, assembly, and final batch release. Notable products include SaliStick, the world's first saliva-based pregnancy test, and the Simply Test range of self-tests. With expertise in biomarker validation, FDA PMA submissions, IVD and companion diagnostic development, Abingdon Health supports clients through complex regulatory pathways and large-scale manufacturing operations.

LCCS Medical Inc. is a privately held manufacturer and distributor of premium specialty medical devices for pain management and regional anesthesia. Founded in 2009 and operating since 2018, the company designs and manufactures RF cannulas, RF electrodes, grounding pads, spinal needles, and epidural needles from medical-grade stainless steel. All products are U.S. FDA approved, with RF cannulas and electrodes also CE marked. The company maintains U.S. headquarters in Peoria, Arizona, and distributes nationwide. LCCS emphasizes precision manufacturing, quality control, and customer service, having maintained zero FDA incidents since market entry. Products are available in both sterile and non-sterile packaging with various configurations to support physician-preferred procedures for pain management, regional anesthesia blocks, and spinal procedures.

AnsibleHealth is a virtual pulmonary rehabilitation and chronic care company delivering tech-enabled home-based healthcare for patients with COPD, congestive heart failure (CHF), and other chronic respiratory conditions. Founded in 2021 and based in Mountain View, California, the company provides virtual consultations with board-certified pulmonary specialists, personalized treatment plans, remote patient monitoring, exercise therapy, health education, smoking cessation support, and care coordination. Operating across all 50 states with multi-payer coverage including Medicare, Medicaid, and major commercial plans (Aetna, UnitedHealthcare, Humana, Anthem, Molina, and others), AnsibleHealth demonstrates strong clinical outcomes: 90% patient satisfaction, 82% symptomatic improvement, 103% increase in physical fitness (sit-to-stand), and 45% reduction in ER visits and hospitalizations. The clinician-led platform partners with top hospital systems (SOVAH Health, Sentara, Carilion Clinic, UVA Health) and employs team members from leading medical institutions and technology companies.

Steelcraft Incorporated is a world-leading OEM manufacturer of medical device delivery systems, IV stands, carts, and wall mounting solutions. Established over 75 years ago and based in Pembina, ND (with historical roots in Kitchener, Ontario), Steelcraft specializes in custom-engineered steel and structural solutions tailored for healthcare applications. The company serves Fortune 500 and industry-leading medical device manufacturers, providing on-time, on-specification, and on-budget manufacturing of hospital infrastructure products including IV transport/delivery systems, medical device mounting solutions, wall mounts, and accessory components. Steelcraft combines precision welding, structural fabrication, and design integration to deliver seamless support systems that enhance device functionality and clinical mobility.

LEADOPTIK Inc. is a deep-tech medical device startup founded in 2020 and based in San Jose, California. The company specializes in advanced pulmonary imaging and biopsy technology for early-stage lung cancer detection. LEADOPTIK develops miniature optical probes utilizing its proprietary Last Inch Assessment™ (LIA™) Technology, which delivers high-resolution, real-time 3D microstructure imaging in ultra-thin formats. This innovation enables access to narrow lung airways that conventional bronchoscopes cannot reach, addressing a critical clinical gap in interventional pulmonology. The LIA™ Technology employs dielectric metasurfaces and nanofabrication techniques to achieve unprecedented precision in nodule assessment and biopsy guidance, reducing diagnostic uncertainty and improving patient outcomes. The company is backed by $5.25 million in funding and supported by leading venture capital partners including SOSV, Sony Innovation Fund, and Meta Venture Partners. LEADOPTIK's clinical advisory board includes pulmonologists from major academic medical centers, and the company is preparing for FDA submission.

Hemostasis, LLC is a FDA-registered, ISO 13485:2016-certified medical device manufacturer specializing in advanced biomaterial-based hemostasis and wound-healing technologies. The company develops and manufactures innovative bleeding-control products utilizing pharmaceutical-grade NOCC chitosan polymer technology. Core offerings include PosiSep® branded hemostat dressings and intranasal splints for ENT sinus procedures, NexStat® and Accel® topical hemostatic powders, BleedArrest® foam sponges, BoneSeal® bone hemostats, and NexFoam® topical hemostat sponges. Products are designed for diverse surgical applications including sinus, cardiac, orthopedic, vascular, soft tissue, and solid organ procedures. The company provides custom manufacturing services for OEMs and maintains active research and development capabilities in bleeding control technologies.

Sirona Complete Care is a specialized distributor of medical imaging accessories for Nuclear Medicine, Nuclear Cardiology, PET/CT, and molecular imaging applications. The company supplies radioactive sources, imaging phantoms, patient positioning systems, radiation detection equipment, and nuclear medicine accessories to healthcare facilities and research institutions. Sirona's product portfolio includes PET sources, survey meters, gamma detection systems, patient support systems, table pads, and theranostics solutions. Known for deep industry expertise, rapid sourcing capabilities, and personalized customer service, Sirona serves as a trusted partner to nuclear medicine technologists, cardiologists, and imaging departments across North America, with particular strength in alternative sourcing and quick-access inventory management.

Medinux (Tianjin) Technologies Co., Ltd is a subsidiary of the Medinux group specializing in medical innovation technology research and new product development with independent intellectual property rights. The company is ISO 13485 certified and operates in a Class 100,000 cleanroom facility. Core product portfolio includes tumor ablation devices, cryopreservation equipment, and tumor ablation detection systems for both domestic and international markets. The organization conducts R&D and manufacturing in strict compliance with GMP standards and has obtained EU ISO 13485 certification. Recent clinical applications include cryoelectrolysis systems for oncology, particularly lung cancer treatment.

Alveo Technologies is a molecular diagnostics company specializing in decentralized, point-of-need pathogen detection platforms. The company's flagship be.well platform integrates sample preparation, nucleic acid amplification, and real-time electrical sensing detection into a palm-sized, portable analyzer delivering results in under one hour. Applications span acute respiratory infections (COVID-19, influenza), avian influenza in poultry, plant pathogens in agriculture, and environmental/wastewater surveillance. The platform is cloud-connected, smartphone-guided, and designed for use by non-specialized personnel in field settings. Alveo serves livestock, food & beverage, companion animal, and public health sectors, with partnerships including Royal GD (Netherlands) for veterinary diagnostics and deployment across Egypt for nationwide avian flu surveillance.

SPR Therapeutics is a Cleveland-based medical device company specializing in peripheral nerve stimulation (PNS) technology for non-opioid, non-surgical pain management. Founded in 2010, the company develops innovative neuromodulation solutions targeting chronic pain, acute pain, post-surgical pain, and post-traumatic pain. The company's flagship product, the SPR® SPRINT® Peripheral Nerve Stimulation System, is the only FDA-approved percutaneous PNS system designed for both chronic and acute indications. SPR Therapeutics' mission centers on providing drug-free alternatives to opioids and invasive surgical procedures, directly addressing the opioid crisis. The company has demonstrated strong clinical evidence with over 200 patents, Department of Defense and NIH funding support, and real-world efficacy showing pain relief in over 70% of patients with more than 50,000 implants performed. SPR continues to advance next-generation pain therapies while expanding market coverage and clinical adoption.

Patriot Medical Distributors is a US-based importer and licensed distributor of specialized medical devices for vascular and lymphatic conditions. The company operates an exclusive DME distribution network across the continental US, Alaska, and Hawaii, representing two flagship product lines: Lympha Press® compression therapy systems for lymphedema and venous disease treatment, and ArtAssist® arterial blood flow enhancement devices supported by over 60 clinical studies. Patriot provides comprehensive support to healthcare providers and patients through insurance reimbursement expertise, clinical education, compliance guidance, and home-based patient care solutions. The company combines 30+ years of product excellence with proven sales infrastructure and specialized knowledge of federal and commercial payer requirements to optimize patient outcomes while managing healthcare costs.

Epicore Biosystems is a digital health and biomedical wearables company specializing in sweat-sensing microfluidic technology. The company develops non-invasive biowearable devices that analyze sweat biomarkers—including electrolytes, metabolites, nutrients, and stress markers—to provide real-time physiological insights. Epicore's proprietary sweat microfluidic sensing platform integrates cloud analytics for personalized health monitoring and decision support. The company's primary solutions target three market segments: industrial safety (workplace hydration and heat stress monitoring), sports and fitness (performance optimization and recovery tracking), and clinical research (biomarker discovery and FDA-registered data collection systems). Epicore's Connected Hydration platform delivers continuous monitoring with real-time alerts, and its Discovery Patch provides laboratory-grade sweat analysis for research applications. The company has established partnerships with major enterprises including Chevron, PepsiCo, Gatorade, and the U.S. Air Force Research Laboratory, deploying solutions across energy, construction, and professional sports sectors.

DERRON Surgical Instruments manufactures premium surgical hand instruments to exacting German manufacturing standards. Specializing in surgical-grade precision instruments, the company offers comprehensive product lines for general surgery, specialty surgical disciplines, and diagnostic procedures. DERRON's portfolio includes scalpel handles, scissors, forceps (dressing, tissue, and hemostatic), needle holders, retractors, and suturing instruments. The company also supplies specialized instruments for dermatology, ophthalmology, otolaryngology, gynecology, cardiovascular, orthopedic, urological, and podiatric surgery. All instruments are produced by master craftsmen with rigorous quality control and backed by a comprehensive warranty against defects in material and workmanship. DERRON serves hospitals, surgical centers, and surgical professionals with custom ordering capabilities and over 50 years of combined instrument expertise.

Corgenix Medical Corporation is a CAP/CLIA-accredited in vitro diagnostics (IVD) company founded in 1990 and based in Broomfield, Colorado. The company specializes in developing, manufacturing, and commercializing diagnostic kits and operates as a Contract Development and Manufacturing Organization (CDMO) serving biotech companies, pharmaceutical firms, cancer centers, and academic laboratories. Corgenix offers over 50 diagnostic tests targeting immunology disorders, cardiovascular and vascular diseases, bone and joint disorders, and viral hemorrhagic diseases. Notable offerings include non-blood-based aspirin effect testing and multiple myeloma monitoring tools. The company provides comprehensive services across the IVD lifecycle: biomarker discovery, assay development, analytical and clinical validation, regulatory submissions, GMP manufacturing, quality control, and commercialization support. With an onsite CAP/CLIA laboratory, Corgenix supports clinical studies, trial management, physician-ordered patient testing, and research initiatives while maintaining strict regulatory compliance and GCP/GLP standards.

Design Standards Corporation is a vertically integrated medical device manufacturer with over 50 years of experience designing and manufacturing disposable and reusable medical devices for leading companies in healthcare. The company specializes in cardiothoracic devices and robotic surgical instruments, leveraging in-house capabilities spanning product design, CAD/Solidworks modeling, injection molding, tooling, and regulatory compliance (ISO 13485:2016). Services include end-to-end product development from concept through production, prototype testing, and manufacturing automation. Core competencies include medical device R&D, product design and development, regulatory assistance, and custom manufacturing of complex surgical instruments and cardiothoracic components.

pfm medical gmbh is a family-owned medical technology manufacturer based in Cologne, Germany, established in 1971. The company develops, manufactures, and distributes approximately 1,800 specialized medical products across four main therapeutic areas: surgery, cardiovascular technologies, histotechnology, and infusion solutions. Key product lines include DURAMESH™ suturable meshes for breast reconstruction and pelvic floor surgery, Nit Occlud® spiral systems for cardiac defect closure, and advanced histology laboratory equipment including the award-winning pfm Forceps EWF 600 wireless heated forceps and the Samui® cooling plate for tissue sample preparation. The company also offers intraoperative imaging solutions such as the ClearCoast™ MRI system for real-time tissue analysis during breast conservation procedures. With over 50 years of operational experience, pfm medical operates 12 locations across 8-10 countries and exports to more than 100 markets worldwide. The company provides comprehensive customer support including compliance training, user education, and technical services to healthcare facilities, medical practices, laboratories, nursing services, and home care providers.

Neuralace Medical is a medical technology company specializing in non-invasive chronic pain management through magnetic peripheral nerve stimulation (mPNS). Their flagship product, Axon Therapy® mPNS, is an FDA-cleared electroceutical platform designed to treat chronic and intractable neuropathic pain conditions including post-traumatic pain, post-surgical neuropathic pain, and painful diabetic neuropathy of the lower extremities. The technology uses high-intensity magnetic pulses delivered at skin level or above to stimulate peripheral nerves and reduce pain signaling without needles, surgical implants, or invasive procedures. Clinical data from the SEAT randomized controlled trial demonstrates significant pain relief, with an average 51% reduction in opioid dependence. Axon Therapy represents a paradigm shift in neuromodulation, offering healthcare providers a stepwise, non-invasive alternative to traditional pain management therapies while maintaining high patient satisfaction and quality of life improvements.

Diowave Laser Systems manufactures FDA-cleared Class IV therapeutic laser systems for pain management, rehabilitation, and regenerative medicine. The company's flagship products—Stealth Lite and Stealth Max—utilize proprietary Stealth Infrared Laser Technology with 810nm wavelength and Stealth Micro-Pulsing to deliver consistent treatment protocols. These systems are used by physicians, sports medicine professionals, veterinarians, chiropractors, orthopedic specialists, and podiatrists for musculoskeletal pain, post-surgical recovery, inflammation, and neuropathic conditions. With over 19 years of Class IV laser expertise and experience from 100,000+ clinical treatments, Diowave provides lifetime clinical training, implementation support, and practice development resources to integrate advanced laser therapy into clinical workflows.

Biotronix Healthcare Industries Inc. is a Canadian medical device manufacturer and global distributor specializing in consumable medical supplies and devices across respiratory, anesthesia, wound care, surgical, cardiology, urological, laboratory, and diagnostic imaging sectors. The company serves hospitals, laboratories, clinics, home healthcare facilities, and government agencies worldwide through an authorized dealer network. Biotronix manufactures safety-engineered products including retractable syringes with safety needles, IV catheters, closed suction catheters, sutures, enteral feeding systems, heat-moisture exchange filters, and specialized procedural trays. The company emphasizes infection control and sharps injury prevention through innovative safety features, such as needle-retraction mechanisms and perforated plunger designs. Biotronix is committed to cost-effective solutions that help healthcare facilities manage budget constraints while maintaining safe, efficient patient care standards.

Methapharm is a specialty pharmaceutical company focused on developing, acquiring, licensing, and promoting healthcare products across North America. Founded in 1996 and based in Coral Springs, Florida, with approximately 85 employees and $19.4 million in revenue, the company operates distribution facilities throughout the United States and Canada with full licensing to distribute prescription drugs. Methapharm specializes in respiratory diagnostics, imaging products, oncology, and neonatology therapeutics. The company's core competency lies in identifying and bringing specialty pharmaceutical products to market that address unmet medical needs in hospital and clinical settings. Key portfolio products include Provocholine (respiratory diagnostic), Aridol, and Tranexamic Acid Injection. Methapharm Respiratory, a dedicated division, has established a strong reputation in respiratory care diagnostics. The company partners strategically with international pharmaceutical manufacturers to distribute specialty products, positioning itself as a critical supply chain partner for healthcare systems requiring access to innovative and hard-to-source pharmaceutical solutions.

Axelgaard Manufacturing Co., Ltd. is a global leader in the design, development, and production of patented electrodes, hydrogels, and specialty medical solutions. Founded in 1985 in Fallbrook, California, the company specializes in manufacturing electrodes for neurostimulation, NMES (neuromuscular electrical stimulation), and TENS (transcutaneous electrical nerve stimulation) therapy applications. The company produces AmGel® hydrogels in bulk rolls for use across cosmetic, dermal, and vital-sign monitoring applications, including ECG electrodes. Axelgaard holds over 55 U.S. and corresponding foreign patents and offers custom and specialty medical device solutions. The company maintains ISO 13485, CE, and MDSAP certifications, with manufacturing based in the USA and global distribution supported from a Denmark facility. Axelgaard is recognized for quality, innovation, and dedicated customer service to healthcare professionals and clinical research partners.

Digirad is a healthcare solutions provider headquartered in Suwanee, Georgia, specializing in diagnostic imaging and mobile healthcare services. Founded in the mid-1990s, the company pioneered solid-state nuclear medicine detector technology and achieved a major milestone in 2000 with the first commercially performed solid-state nuclear medicine scan. Digirad operates nationwide, delivering on-demand diagnostic services across four key segments: diagnostic services, mobile healthcare, diagnostic imaging, and medical device sales and services. The company serves a diverse customer base ranging from small practices to large hospital systems, offering nuclear and ultrasound imaging, contract-based diagnostic imaging, and solid-state nuclear imaging systems. Digirad emphasizes point-of-care convenience and scalable solutions that enhance operational efficiency for healthcare providers.

Akesis, Inc. is a medical device manufacturer specializing in advanced radiation therapy systems for oncology and neurosurgery applications. Founded in 2017 and based in Concord, California, the company develops stereotactic radiosurgery (SRS) and linear accelerator platforms featuring patented continuous 360° rotational technology with real-time imaging capabilities. The Akesis Galaxy Platform combines gamma-beam therapy with rotational delivery to optimize treatment planning and dose distribution, while the Akesis Gemini360RT is a modularized linear accelerator platform with multiple imaging options. Both systems support fractionated and single-fraction treatments with high conformality and real-time guidance. Akesis serves healthcare providers ranging from small rural centers to large academic health systems and has received FDA 510(k) clearance for its platforms.

TaeWoong Medical Co., Ltd. is a South Korean medical device manufacturer founded in 1991, specializing in minimally invasive medical devices with a global footprint in over 70 countries. The company is recognized for its self-expandable metallic stents under the Niti-S™ brand, securing CE certification (2000) and regulatory approvals in Japan, USA, and China. TaeWoong Medical's product portfolio spans gastroenterology, urology, and interventional cardiology, including biliary stents, pancreatic stents, and endoscopic RFA (radiofrequency ablation) accessories. Recent innovations include PULSTA™, a CE MDR Class III certified pulmonary valve for congenital interventional cardiology. The company emphasizes quality, patient outcomes, and ongoing R&D, with active participation in major international medical conferences (DDW, UEGW, APDW, ESGE, JCIC).

ZeptoMetrix is a leading biotechnology company specializing in quality controls, assay development services, analytical reference materials, and proficiency testing for infectious disease diagnostics and analytical markets. Founded in 1999 and headquartered in Buffalo, New York, the company operates as a division of Antylia Scientific. ZeptoMetrix serves diagnostic microbiology, oncology, environmental testing, food & agriculture, cannabis & hemp, and pharmaceutical sectors. The company offers molecular controls for diagnostic testing, analytical reference materials including certified reference materials (CRMs) for environmental contaminants (PFAS, microplastics, pesticides, organotins), food safety standards, cannabis potency testing compounds, and pharmaceutical reference standards. ZeptoMetrix provides ISO 17043-accredited proficiency testing programs, viral lysates and culture fluids, seroconversion panels, monoclonal and polyclonal antibodies, ELISA kits, microbiological controls, and oncology molecular controls. With approximately 106-200 employees and ~$10M annual revenue, ZeptoMetrix serves global customers through direct sales and distributor networks, supported by comprehensive technical documentation and regulatory compliance resources.

Vidan Diagnostics is a B2B medical diagnostic supplier headquartered in San Antonio, Texas, specializing in laboratory diagnostic reagents and assays for critical clinical areas. The company distributes high-quality, FDA-cleared diagnostic products focused on diabetes management, sepsis biomarker detection, cardiovascular disease assessment, and anemia diagnosis. As the exclusive U.S. distributor for DiaSys Diagnostic Systems' Procalcitonin FS Assay, Vidan serves hospital laboratories and clinical diagnostic facilities with proven, easy-to-use technology platforms. The company's product portfolio emphasizes biomarker-based testing to improve patient outcomes and reduce hospital mortality, particularly in sepsis and chronic disease management.

CardioQuip is a US-based manufacturer of perfusion equipment specializing in cooler-heater devices for open-heart surgery and cardiac procedures. Originally established as a refurbisher of perfusion devices, the company leveraged extensive feedback from surgeons, biomeds, and perfusionists to design and manufacture innovative temperature control solutions. CardioQuip's flagship MCH-1000 series—including the MCH-1000(i) and MCH-1000(m) models—delivers precise patient temperature management with intuitive touchscreen interfaces, simplified cleaning protocols, and enhanced safety features. The MCH-1000(i) provides best-in-class performance with a 36L insulated tank and 1600W heating capacity, while the compact MCH-1000(m) offers full-sized performance in a space-conscious footprint. The VivaCart™ (VC-1000) provides portable transport and integration with most perfusion pumps. All equipment is designed and manufactured in the USA. CardioQuip also provides comprehensive technical support, preventive maintenance programs, and regional distribution services across North America and internationally.

Neurolief is a neuromodulation medical device company specializing in non-invasive, FDA-approved brain stimulation systems for treating major depressive disorder (MDD), migraines, stress, and sleep disorders. The company's flagship product, Proliv™Rx, delivers combined occipital and trigeminal afferent stimulation (eCOT-AS) as a home-based, physician-directed adjunctive therapy for adults with treatment-resistant depression who have failed antidepressant medications. The system enables 8-16 week treatment programs delivered entirely at home with continuous clinician oversight and symptom tracking, eliminating the need for specialized clinic infrastructure, staffing burden, or geographic limitations. Clinical evidence demonstrates 87% of patients show improvement in depression severity with 96% treatment adherence. Proliv™Rx is FDA-approved in the USA, CE-marked in Europe, and PMDA-approved in Japan. The company also offers wearable neuromodulation devices including Relivion MG for acute and preventive migraine relief. All solutions leverage intelligent companion apps enabling remote patient monitoring and personalized treatment management outside traditional clinical settings.

MannKind Corporation is a biopharmaceutical company focused on innovative drug delivery technologies, particularly inhaled therapies for chronic diseases. Founded in 1991 and headquartered in Danbury, Connecticut, MannKind specializes in treatments for cardiometabolic diseases, orphan lung diseases, pulmonary hypertension, and fluid overload in heart and chronic kidney disease. The company utilizes its proprietary Technosphere® platform for pulmonary drug delivery. Key marketed products include Afrezza® (inhaled insulin for diabetes), V-Go® (all-in-one insulin delivery patch), FUROSCIX® (furosemide injection for fluid overload), and Tyvaso DPI® (treprostinil inhalation powder for pulmonary hypertension, utilizing Technosphere technology under partnership with United Therapeutics). MannKind is committed to enhancing patient outcomes through transformative therapies and ongoing clinical development across endocrine and orphan lung disease indications.

Infinity Medical Wellness is a luxury primary care and regenerative medicine clinic located in Brickell, Miami, Florida. Led by Diana Aristizabal, MSN, APRN, FNP-BC, the clinic specializes in personalized, concierge-style medical care with expertise in addiction medicine, ketamine therapy for treatment-resistant depression, and regenerative interventions including platelet-rich plasma (PRP) joint injections. Services encompass comprehensive primary care, IV ketamine and vitamin infusions, hormone replacement therapy, weight loss management, chronic pain management including migraine treatments, adolescent medicine, mobile house call services, and in-house laboratory testing. The clinic emphasizes a patient-centered, luxury wellness approach with a focus on tissue regeneration, pain management, and comprehensive health optimization through innovative pharmaceutical and procedural interventions.

Belmont Medical Technologies is a medical device manufacturer specializing in fluid warming, fluid management, and patient temperature regulation solutions for critical care environments. The company develops precision-controlled devices designed for hospitals, surgical centers, emergency transport, military combat fields, and EMS settings. Belmont's portfolio addresses hypothermia prevention, intraoperative normothermia maintenance, and therapeutic temperature management. The Belmont® Rapid Infuser RI-2 delivers warmed blood and fluids at rates from 2.5 to 1000 ml/min with automatic air detection; buddy lite® provides portable, battery-powered warming for field and transport use; Allon® and CritiCool® systems maintain perioperative body temperature non-invasively using algorithm-driven heat pumps and disposable patient garments; and the Hyperthermia Pump™ performs intraperitoneal and thoracic hyperthermic lavage with electromagnetic induction heating. All disposables are aluminum-free and feature intuitive touchscreen interfaces. Belmont has earned significant U.S. military contracts for fluid resuscitation and temperature management.

ISO 13485:2016 certified, FDA-approved medical device manufacturer specializing in respiratory, anesthesia, emergency, and critical care components. Instrumentation Industries supplies a comprehensive range of ventilator circuit accessories including connectors, adapters, exhalation valves, tubing, and water traps. The company manufactures manual jet ventilators, endotracheal tube changers, MDI adapters, and pressure/vacuum gauges. Products also include airway management devices, oxygen delivery systems, breathing bags, and silicone rubber connectors—many featuring reusable, autoclavable designs. Founded in 1967 and based in Pittsburgh, PA, the company serves respiratory therapists, emergency medical services, and critical care facilities with high-precision, difficult-to-find medical components manufactured domestically.

Carbo Trading Co. Inc. is a B2B medical supplier specializing in acupuncture needles, traditional Chinese medicine products, and clinical medical supplies. The company offers an extensive catalog including various acupuncture needle formats (blister pack, foil pack, cluster pack, specialty needles), ear seeds, moxibustion products, massage equipment, examination tools, surgical instruments, diagnostic devices, and disposable clinical consumables. Product lines span from traditional modalities such as cupping sets, gua sha tools, and TDP lamps to modern clinical supplies including stethoscopes, blood pressure units, thermometers, examination gloves, and gauze bandages. The company serves practitioners and healthcare facilities with both traditional Chinese medicine practitioners and clinical settings, offering training models, reference materials, and comprehensive product catalogs.